Carilion Clinic Joins Forces with Civica to Enhance Medicine Supply Access

In an important development for healthcare accessibility, Carilion Clinic officially joined Civica as a Founding Member on September 15, 2026. The announcement underscores a collaborative effort to ensure a stable supply of essential generic medicines for the patients who turn to Carilion for care. Civica, a nonprofit pharmaceutical organization, was established in response to the growing issue of drug shortages in the United States, which have significantly impacted healthcare delivery.

Civica was launched in 2018 by a coalition of philanthropy organizations and leading U.S. health systems that directly faced the detrimental consequences of drug shortages. These shortages not only hinder the delivery of timely medical care but also pose risks to patient outcomes. The organization aims to provide a consistent supply of essential medications through an innovative and collaborative business model designed to prioritize the needs of patients in the generic drug marketplace.

Since its inception, Civica has made remarkable strides, providing sufficient medication to treat over 100 million patients in the U.S. The unique model operates on a member-led structure, encouraging healthcare institutions to identify and prioritize specific medications that hospitals and patients require. This collaborative approach allows member hospitals, including Carilion Clinic, to have a say in which medications should be prioritized based on their availability and the frequency of shortages.

Carilion Clinic serves a diverse population of over 1 million individuals across Virginia and West Virginia. The move to join Civica reflects a shared commitment to ensuring dependable access to essential medicines. Jennifer Spalding, Chief Commercial Officer of Civica, expressed optimism about the partnership, highlighting its potential to improve supply chain reliability and reduce the burden of drug shortages. “By bringing together mission-driven health systems and partners, we can improve our services and better address the needs of our communities,” she said.

Chad Alvarez, System Pharmacy Director for Carilion, emphasized how this partnership will directly enhance medication access. He noted that the collaboration will enable Carilion to leverage Civica’s robust supply chain to combat prevalent drug shortages effectively. This relationship also opens avenues for selecting medications that can be manufactured domestically, thus creating more reliable sourcing for essential drugs that are often in short supply.

Civica’s model prioritizes the stability of the market by committing to long-term contracts and maintaining a safety stock of up to six months for essential medications. Such strategies help to safeguard against future shortages, ensuring that healthcare providers can deliver consistent care without interruption.

As part of its mission to improve health outcomes, Carilion Clinic continuously strives to advance patient care through its network of healthcare services, which includes hospitals, physician practices, and specialty departments. The organization’s commitment to education, research, and innovation is further exemplified through its partnerships with educational institutions like the Virginia Tech Carilion School of Medicine.

In conclusion, the collaboration between Carilion Clinic and Civica marks a significant step toward addressing the ongoing challenges posed by drug shortages. As the healthcare landscape continues to evolve, partnerships like these will play a crucial role in ensuring that all patients have access to the medications they need for their care, ultimately enhancing the overall quality of healthcare delivery in the United States.